https://orcid.org/0000-0001-6011-6708
Figures
Abstract
This study aims to introduce a new index that could become a framework for future modification and improvement, and retrospectively test the predictability of this index collectively and individually for final bone changes by using existing research data pertinent to guided bone regeneration (GBR).
Methods
The MAPS score was introduced to evaluate the bioMechanical, Aesthetic/Anatomical, Pathophysiologic, and Subject-related parameters for the healing assessment of 20 patients who underwent GBR in the posterior mandible retrospectively. Intraoral photography was taken at 3-, 10-, 21 days, and 5 months, resulting in 80 follow-up visits. Two independent examiners evaluated the photos giving scores for each timepoint and tested against horizontal bone gain (CBCT) for predictability.
Results
Cohen’s Kappa values showed high intra- and inter-examiner agreement. Pearson’s correlation showed an inverse correlation between baseline bone width and bone changes at a 3 mm level (R2 = 0.23). The higher M, A, and P values at any time point were associated with higher bone gain. The 10-day MAPS score turns out the most predictive of bone gain (RMSE 1.32, R2 0.75). In addition, increasing the average P score by 1 point at 10 days is associated with an increase in bone gain of 1.23 (p=.057).
Conclusion
The MAPS score improves consistently over the 5-month healing period. However, no statistically significant difference is observed between the scores at 21 days and 5 months, reflecting the clinical healing pattern for GBR. The overall MAPS score correlated with bone changes after GBR procedures, indicating its potential for estimating hard tissue regenerative outcomes.
Citation: Rodriguez A, Velasquez D, Marquez L, Ramos JM, Zambrana N, Masotti M, et al. (2025) Introduction of “MAPS” wound healing index and its correlation with guided bone regeneration outcome. PLoS ONE 20(3): e0319271. https://doi.org/10.1371/journal.pone.0319271
Editor: Tanay Chaubal, International Medical University, MALAYSIA
Received: September 15, 2024; Accepted: January 29, 2025; Published: March 20, 2025
Copyright: © 2025 Rodriguez et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Data contain potentially sensitive information. The University of Michigan Institutional Review Boards (IRB) may need to be contacted to access raw data. Concat information: Institutional Review Boards (IRBMED) Room 3214 North Campus Research Complex, Building 520 2800 Plymouth Road Ann Arbor, MI 48109-2800 Phone: 734-763-4768 Fax: 734-763-1234 Email: irbmed@umich.edu.
Funding: This study was partially supported by BioXclude, Snoasis Medical, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
1. Introduction
Wound healing monitoring after oral surgeries is crucial to ensure the recovery is on the right track [1,2]. Several synchronized biological events occur during the healing, including hemostasis, inflammation, proliferation, wound remodeling, and maturation [1,3]. In these intricate wound healing phases distinct types of cells, cytokines, growth factors, and extracellular matrix components participate at certain times and duration [1,2,4]. Deviation from the normal course results in a variety of clinical presentations and surgical outcomes [2,5–10]. Clinically, different indices have been proposed for periodontal wound healing as a result of soft and hard tissue surgical procedures [1,3,5,6,8,9,11–22]. Although these indices are different in aspects of the parameters used, the scoring mechanism, complexity, and the evaluation timing, by dissecting them there seem to be common themes that encircle around these healing phases [1,3,6,8,11,12,7–28]. Identifying and applying the key common parameters that already exist among the currently available indices could improve our understanding of wound healing evaluation.
Guided bone regeneration (GBR) is a surgical procedure performed to preserve and/or increase alveolar bone volume for proper implant function and esthetics [24,29–38]. Clinical and histologic evidence of its effectiveness has been demonstrated [29,35,39,40]. Yet a desirable outcome is in part guarded by the systemic conditions of the patient, hard and soft tissue characteristics, biomaterial selections, and clinician’s experience [24,33,37,38,41–44]. Complications may arise leading to inferior bone gain, including soft tissue lesions such as dehiscence, membrane exposure, tissue necrosis, acute infection, abscess, and wound opening [24,37,38,41]. These complications may appear more frequently in patients with systemic and behavioral risk factors, such as smoking history and uncontrolled diabetes [13–15,32,33,35–38,41–43,45–47]. When the surgical sites remain undisturbed during the initial healing phase, regenerative success will have a higher chance to occur. An uneventful soft tissue healing maintains the stability of the underneath biomaterial, nourishes the surgical site, and forms a protective barrier against biological and mechanical irritation [24,33,35,37,38,41,46,47]. Since GBR is an invasive, and expensive procedure with a long healing time, timely and effective wound evaluation and management could avoid or mitigate potential negative outcomes so as to benefit the patients.
Soft tissue dehiscence and membrane exposure are common after GBR, accounting for approximately 20% of the cases [24]. Significantly less bone gain was found with membrane exposure [37,47,48]. A classification of postoperative complications in GBR by using a non-resorbable membrane was presented ([49]. It is based on the size of the membrane exposure, presence of purulent exudate and abscess formation. Other clinical signs and symptoms that may be related to the healing status and ultimately the amount of bone augmentation should also be systematically evaluated. Given the growing application of GBR and a need for a better understanding of GBR wound healing, this study aims to (1) introduce a new index that could become a framework for future modification and improvement, and (2) retrospectively test the predictability of this index collectively and individually for final bone changes by using existing research data pertinent to GBR procedures.
2. Materials and methods
The study was approved by the University of Michigan Medical School Institutional Review Board (IRB) (HUM00161016) in accordance with the Helsinki Declaration of 1975, as revised in 2013. A written informed consent was obtained from all participants before their inclusion in the study. The recruitment period was from 7/23/2021 to 5/4/2023.
2.1. Introduction of the “MAPS” oral wound healing index
Previous wound healing indices have identified some overlapping but distinct key parameters that are essential for assessing wound healing outcomes [1,3,9,11,7,17,19–22,50,51]. To sort these parameters and evaluate their collective as well as relative correlation to the guided bone regeneration outcomes, the “MAPS” wound healing index is herein introduced. The acronym “MAPS” stands for “bioMechanical, Aesthetic/Anatomical, Pathophysiologic, and Subject-related,” as illustrated in Fig 1. These four domains serve as a comprehensive framework for categorizing the key clinical parameters that are significantly related to wound healing. Within each domain, points are given based on a scale of 1 (compromised), 2 (questionable), 3 (normal), to 4 (optimal) for the evaluated parameters, as outlined in Table 1.
A comprehensive framework for categorizing the key parameters of wound healing.
2.1.1. Biomechanical domain.
This domain assesses wound edge approximation influenced by the biomechanics of the wound, e.g., residual flap tension, muscle pull, suture tightness, biomaterial stability, etc., during the healing time. The 4-point scale is proposed as:
- 1 point: an open wound margin through the full soft tissue thickness. The underlying biomaterials can be felt or seen up on light separation of the margin.
- 2 points: an open wound margin but not through the full thickness. The underlying biomaterials are not felt or seen.
- 3 points: edge-to-edge margin contacts but with a visible incision line.
- 4 points: merged margins with disappearance of the incision line.
2.1.2. Aesthetic/Anatomical domain.
Wound healing can and has been assessed by the esthetic outcome, reflected by the degree of soft tissue harmony of the surgical site compared to adjacent sites. Soft tissue quality and quantity are evaluated separately. Soft tissue quality that impacts esthetics may include the presence of keloid, inadequate keratinized mucosa, and color changes. Soft tissue quantity that compromises esthetics may include loss of interdental papilla, facial tissue height, and overall tissue volume. To define the degree of discrepancy as:
- 1. Major: Significant differences in tissue quality and/or quantity, with noticeable changes in texture (presence of keloid), inadequate keratinized mucosa, color, or contour at the surgical site compared to adjacent sites.
- 2. Moderate: Some visible differences in tissue quality or quantity, but not as pronounced as in the major discrepancy category. Minor changes may be noted in texture, color, or contour.
- 3. Minor: Subtle differences in the quality or quantity of soft tissue, with only slight deviations from adjacent areas, often not easily noticeable under normal conditions.
- 4. No: The soft tissue at the surgical site appears identical to that of the adjacent sites, with no visible differences in texture, color, contour, or keratinized mucosa band.
In cases not in the esthetic zone, the soft tissue anatomical changes related to the quality and quantity after the surgery is evaluated.
2.1.3. Pathophysiological domain.
This domain relates to host reactions in response to trauma from the surgical incision and flap management, and bacterial challenge. Five parameters are evaluated:
- Infection signs: 1 point, spontaneous suppuration or on light palpation; 2 points, evident exudate on light palpation; 3 points, slight exudate upon compression of the wound; 4 points, no exudate.
- Hemostasis: 1 point, spontaneous bleeding; 2 points, bleeding at the incision margin with provocation; 3 points, presence of fibrin at the incision margin; 4 points, absence of fibrin at closed incision margin.
- Tissue perfusion (blood supply): 1 point, entire flap necrosis, 2 points, partial soft tissue necrosis at the critical site, e.g., bone graft placement site, 3 points, necrosis at the focal, non-critical site, e.g., adjacent to a tooth; 4 points, no necrotic tissue, and appearance of adequate perfusion.
- Tissue color as a sign of inflammation: 1 point, significant discoloration, e.g., redness; 2 points, moderate discoloration; 3 points, slight discoloration; 4 points, normal appearance as adjacent tissue.
- Epithelialization: 1 point, absent; 2 points, partially present; 3 points, fusion of the wound surface but with evidence of wound surface depression; 4 points, complete fusion of the wound surface by epithelium without depression.
2.1.4. Subject domain.
This is related to patient-reported outcome evaluation, including
- Discomfort: Changes in pain levels were assessed using a scale from 1 to 4, where 1 point, severe; 2 points, moderate; 3 points, slight; 4 points, absent.
- Habit change/function impairment: Changes in habits were evaluated, specifically medication use (including ibuprofen and other medications), as well as functional changes, such as any loss of function, at multiple time points following surgery for both the test and control Groups. The scoring system for medication use was as follows: 1 point for severe use, indicating the need for additional medications beyond the allotted daily dose; 2 points for moderate use, defined as taking the prescribed daily medication dose; 3 points for slight use, characterized by taking half or less of the indicated dose; and 4 points for no use of medications. For the loss of function scale, the scoring was as follows: 1 point for severe impairment; 2 points for moderate impairment; 3 points for slight impairment; and 4 points for no loss of function.
2.2. Population and settings
We conducted a retrospective analysis of the healing outcomes of 20 patients who underwent guided bone regeneration (GBR) due to 1-3 mm lateral bone deficiency in the posterior mandible with 1-2 adjacent missing teeth. The study was approved by the University of Michigan Medical School Institutional Review Board (IRB) (HUM00161016) in accordance with the Helsinki Declaration of 1975, as revised in 2013. An informed consent was obtained from all participants before their inclusion in the study. The study design was a randomized controlled trial involving using an amnion-chorion membrane (BioXclude, Snoasis Medical, USA) for the open wound concept as the test group, compared to the closed wound approach using a collagen membrane (ORAMEM, Salvin, USA). Clinical intraoral photography was taken to record the healing progress of patients during four follow-up appointments, which occurred at 3 days, 10 days, 21 days, and 5 months, respectively, resulting in a total of 80 follow-up visits. All patients were treated with 70:30 mineralized and demineralized allograft bone substitutes (Maxxeus, Dayton, OH, USA).
2.3. Measurements and outcome projection
Two independent examiners (AR and LM) evaluated the 3 standard intraoral photos taken on the occlusal, facial, and lingual sides at each time point for each wound, totaling 80 follow-up visits for the Biomechanical (1 parameter), Aesthetics (2 parameters), Pathophysiological (5 parameters) Domain’s evaluations. Subject-related outcomes were interpreted from the surveys given to the patients for the Subjective Domain (2 parameters). At each visit, the overall score per each domain was averaged (as shown in Table 1 and Fig 1). A summary score of each wound was calculated by averaging the overall scores of the 4 Domains. Intra-examiner agreement was evaluated by measuring 3 cases twice 15 days apart for memory washout. The MAPS score and the score from each Domain was tested against the 5-month CBCT bone changes to evaluate its predictability. Pre-op and 5-month CBCT images were superimposed using the common references with software (Romexis, Planmeca Oy, Helsinki, Finland). Bone changes at 1-, 3- and 5-mm levels from the edentulous crest were measured with the built-in caliper to 0.01 mm by another masked investigator, a maxillofacial radiologist (NZ), as shown in Table 2.
2.4. Statistical analysis
Cohen Kappa’s correlation coefficient was used to evaluate the intra-examiner and inter-examiner agreement for categorical variables with a 95% confidence interval. Inter-examiner agreement was calculated as an overall MAPS score and per individual parameters of the score to evaluate inter-examiner and intra-examiner reliability. A substantial agreement is present when values ranged from 0.6-08, and perfect agreement ranges between 0.8-1. The mean MAPS score was plotted against the time (3, 10, and 21 days and 5 months) and compared with one-way ANOVA to see the changes over time. Linear regression analyses were performed to correlate the MAPS score with radiographic bone changes. A two-tailed p-value of less than 0.05 was considered statistically significant for all tests. Statistical analysis was performed using Graph Pad Prism and R version 4.2.1.
3. Results
The patients had a mean age of 58 years (range 27 to 83), with 3 men (15%) and 17 women (85%). The surgical procedure was performed in the posterior mandible (Right/left side ratio 11(55%)/9 cases (45%). Collagen membranes were used in 10 cases (50%), whereas amnion-chorion membranes (BioXclude, Snoasis Medical LLC, USA) were used in 10 cases (50%). The mean CBCT bone changes were 0.14 mm (SD = 2.63 mm, range -6.48 to 3.52 mm), 1.50 mm (SD = 2.54 mm, range -4.86 to 7.31 mm), and 1.41 mm (SD = 1.74 mm, range -1.35 to 5.96 mm) at 1-, 3-, and 5-mm levels from the bone crest, respectively. Pearson’s correlation showed an inverse correlation between baseline bone width and the bone changes at a 3 mm level (R2 = 0.23) (Fig 2). The mean CBCT bone gain for the test group at the 1 mm level was -1.86 mm (SD = 2.58, range: -3.25 mm to 0.27 mm), at the 3 mm level was 0.52 mm (SD = 4.14, range: -1.08 mm to 7.31 mm), and at the 5 mm level was 0.95 mm (SD = 2.09, range: -0.135 mm to 5.96 mm). In comparison, the mean CBCT bone gain for the control group at the 1 mm level was 0.77 mm (SD = 2.77, range: -1.45 mm to 3.52 mm), at the 3 mm level was 2.43 mm (SD = 1.58, range: -0.86 mm to 4.05 mm), and at the 5 mm level was 1.67 mm (SD = 1.60, range: -0.81 mm to 3.51 mm). Additionally, a statistically significant difference in bone gain was observed at the 1 mm level between the test and control groups (p = 0.04). However, no significant differences were found in bone gain at the 3 mm and 5 mm levels between the two groups (p = 0.21 and p = 0.40, respectively).
Bone gains exploratory plots show approximately normally distributed (B).
Regarding the “S” subject domain, while the test and control groups initially differed in pain levels and ibuprofen usage during the early post-operative phase, with the test group using more ibuprofen on Days 1 and 2 (P = 0.04), these differences diminished over time. Additionally, no significant differences were observed in the use of other medications between the two groups (p > 0.05).
3.1. Intra- and inter-examiner agreement
Cohen’s Kappa values for Examiner 1 and 2 showed intra-examiner agreement of 0.94 (Minimal = 0.74 and Maximal = 1.00) and 0.66 (Minimal = 0.38 and Maximal = 1.00), respectively (Table 3). Inter-examiner agreement for the parameters in the 4 Domains ranged from 0.77 to 1.0. (Tables 4 and 5).
3.2. MAPS score changes overtime
The mean score was 2.7 (SD = 0.7), 2.7 (SD = 0.6), 3.1 (SD = 0.6), and 3.6 (SD = 0.3) at 3-, 10-, and 21-day, and 5-month visits, respectively, suggesting an overall resolution of inflammation and improvement in soft tissue tone. The scores between 3-day and 5-month visits and 10-day and 5-month visits were significantly different (p < 0.0001) (Fig 3). Figs 4 and 5 showed examples of compromised and favorable healing with clinical occlusal photos and baseline as well as 5-month CBCT images. In addition, a scatterplot of the mean individual MAPS scores parameters (of both examiners) over time (up to day 21) is presented. The color scale bar indicates bone gain, where dark blue can be seen as negative bone gain (up to -2.5 mm), light blue no gain ( ~ 0 mm), dark green mild bone gain (up to 2.5 mm), light green moderate bone gain (up to 5 mm), and yellow high bone gain (>5 mm). Preliminary results indicate that higher M, A, and P values at any time point were associated with higher bone gain (Fig 6). The mean MAPS scores for the test group at the 3-day, 10-day, 21-day, and 5-month visits were 2.8 (SD = 0.8), 2.7 (SD = 0.6), 2.7 (SD = 0.6), and 3.5 (SD = 0.3), respectively. For the control group, the mean MAPS scores at the same time points were 2.7 (SD = 0.6), 3.1 (SD = 0.6), 3.5 (SD = 0.4), and 3.8 (SD = 0.2), respectively.
Top row shows clinical intraoral photography from baseline (BL), 3 days (D3), 10 days (10D), 21 days (D21), and 5 months (5M). Bottom row shows CBCT bone width measurements at baseline (BL), 5 months (5M). There is evidence of inferior bone gain seen in clinical photos over time due to compromised healing and shown in bone loss measurements in the follow-up CBCT.
Top row shows clinical intraoral photography from baseline (BL), 3 days (D3), 10 days (10D), 21 days (D21), and 5 months (5M). Bottom row shows CBCT bone width measurements at baseline (BL), 5 months (5M). There is clear evidence of superior bone gain seen in clinical photos over time due to optimal healing and shown in bone gain measurements in the follow-up CBCT.
The color scale bar indicates bone gain, where dark blue can be seen as negative bone gain (up to -2.5 mm), light blue no gain ( ~ 0 mm), dark green mild bone gain (up to 2.5 mm), light green moderate bone gain (up to 5 mm), and yellow high bone gain (>5 mm). Higher M,A, P at any time point is associated with higher bone gain.
When comparing the test and control groups, no statistically significant differences were found in the overall MAPS scores at the 3-day and 10-day visits (p = 0.70, SD = 0.73; p = 0.14, SD = 0.61, respectively). However, a statistically significant difference was observed at the 21-day and 5-month visits (p = 0.001, SD = 0.60; p = 0.06, SD = -0.28, respectively). Specifically, the control group showed higher overall MAPS scores than the test group at both 21 days (3.5 vs. 2.7, respectively) and 5 months (3.8 vs. 3.5, respectively).
3.3. MAPS score vs. radiographic bone changes
Because of the high inter-observer agreement, the MAPS scores were averaged from 2 observers to plot against the radiographic bone changes. Statistically significant correlations were found between the 3-day mean score and 3-mm bone gain (R2 = 0.7, p = 0.01), 10-day mean score and bone gain at 1 mm (R2 = 0.47, p = 0.006,), 3 mm (R2 = 0.29, p = 0.02,), and 5 mm (R2 = 0.24, p = 0.042) levels. The correlations of 21-day mean score and bone gain were also statistically significant at 1 mm (R2 = 0.58, p = 0.0009,), 3 mm (R2 = 0.46, p = 0.0026,), and 5 mm (R2 = 0.31, p = 0.019) (Fig 7).
There is statistical significance of bone gain at 1, 3, and 5 mm at 10 and 21 days when compared to the MAPS score (p-value < 0.05). MAPS score correlated with bone changes after GBR procedures, indicating its potential for estimating hard tissue regenerative outcomes.
Furthermore, the bone gain at 1, 3, and 5 mm were compared between the combined MAPS scores of 1-2 (lower MAPS) and 3-4 (higher MAPS) at 3, 10, and 21 days. At day 10, the 3-mm bone gain was significantly more in the higher MAPS (mean = 3.29 mm, SD = 1.84 mm) than in the lower MAPS group (mean = 0.02 mm, SD = 2.32 mm, p = 0.002). (Fig 8). Additionally, when analyzing the MAPS scores versus radiographic bone gain in both the test and control groups, the findings showed that in the test group, the correlations between the mean MAPS scores at 3 days, 10 days, 21 days, and 5 months, and bone gain at the 1-, 3-, and 5-mm levels were statistically significant (p < 0.05 at all levels and all follow-up time points). In contrast, in the control group, the correlations between the 3-day mean MAPS score and bone gain at the 3- and 5-mm levels did not show statistically significant differences (p = 0.37 and p = 0.11, respectively). However, in the control group, statistically significant correlations were found between the 3-day mean MAPS score and bone gain at the 1-mm level, as well as between the 10-day, 21-day, and 5-month mean MAPS scores and bone gain at the 1-, 3-, and 5-mm levels (p < 0.05 for all).
There is statistical significance for bone gain at 3 mm when correlated with the grouped low and high MAPS scores (p-value < 0.005).
3.4. Statistical modeling
Linear regression models were used to identify the time point (3, 10, 21 days, and 5 months) that fit the best with the 3-mm bone gain, which is clinically relevant in this indication, compared to 1-mm and 3-mm levels. The 10-day MAPS score turns out the most predictive of bone gain, with the lowest RMSE (1.32) and highest R2 (0.75), calculated by the method of leave-one-out-cross-validation (Table 6). Next, a stepwise procedure was used to perform variable selection. The best model, selected via AIC contained only the average A score, average P score, and baseline bone width. Regression coefficients and 95% confidence intervals are provided in Table 7. Increasing the average A score by 1 point at 10 days is significantly associated with an increase in bone gain of 1.6 (95% CI: 0.54-2.66, p = .006). In addition, increasing the average P score by 1 point at 10 days is associated with an increase in bone gain of 1.23 (95% CI: -0.04-2.51, p = .057). Finally, increasing the baseline 3mm-bone width by 1 mm is associated with a decrease in bone gain of 0.76 mm (95% CI -1.07 to 0.46, p < .001) (Table 8).
4. Discussion
4.1. Primary findings
In this study, the MAPS index was evaluated for the healing assessment of 20 patients who had a GBR procedure using 2 types of resorbable membranes for correcting minor (1-3 mm) lateral ridge deficiency. The available data suggested an acceptable reproducibility of this index at both intra-examiner (κ= 0.94 for examiner 1 and κ=0.66 for examiner 2) and inter-examiner levels (κ= 0.89).
The MAPS score shows continuous improvement throughout the 5-month healing period. However, there is no statistically significant difference between the Day 21 and 5-month scores, which reflects the typical clinical healing pattern observed with collagen membranes in GBR (Fig 3). The overall MAPS score correlated with bone changes after GBR procedures, indicating its potential for estimating hard tissue regenerative outcomes (Figs 6 and 7). More specifically, the 10-day seems reliable and practical to predict the healing outcome, based on the fit linear model. Comparisons in bone changes were made between MAPS scores of 1-2 and 3-4, showing at the 10-day follow-up, normal/accelerated healing scores showed a statistically significant bone gain compared to compromised/delayed healing scores (Fig 8). Furthermore, of the 4 Domains that contribute to the MAPS score, the stepwise analyses suggest the Aesthetic/Anatomical (A) and Pathophysiological Domains (P) correlate with 5-month bone changes (Tables 7 and 8). Preliminary evidence indicates early soft tissue healing related to inflammation status and tissue features may predict final hard tissue healing outcomes [1–3,6,11]. The biomechanical and subject-related domains, even not correlated with the outcome, should be carefully evaluated as an integral part of wound healing evaluation. Additionally, the mean CBCT bone gain for the test group showed bone loss of -1.86 mm at the 1-mm level, compared to a marginal gain of 0.77 mm in the control group, which was statistically significant. No significant differences were observed at the 3-mm and 5-mm levels. However, the control group exhibited higher bone gain at the 1-, 3-, and 5-mm levels compared to the test group.
For the MAPS scores, no significant differences were found at the 3-day and 10-day visits. However, significant differences were observed at both the 21-day and 5-month visits, with the control group showing higher MAPS scores at both time points (21 days: 3.5 vs. 2.7; 5 months: 3.8 vs. 3.5). When analyzing the correlation between MAPS scores and bone gain, the test group showed lower bone gain and MAPS scores at the 1-mm level compared to the control group. While no significant differences were found at the 3-mm and 5-mm levels, the control group demonstrated higher bone gain at these levels. These results were further supported by the significant differences in MAPS scores at 21 days and 5 months, favoring the control group.
4.2. Inclusion of the current literature and emerging technology
The MAPS Index encompasses the key parameters that was included in the existing indices [2,3,11,12,7–18,20–22]. These parameters are categorized into the 4 domains that are closely tied to the sequences of wound healing, soft tissue changes, and patient-centered outcomes. Previous healing indexes examine the patient’s perception verbally and wound appearance “visually” [18–22]. Emerging evidence shows biomechanical homeostasis relies on a balance between the suture tension, flap contraction from internal stress, swelling and muscle pulling during function, and biomaterial stability [2,14,15,22,52,53]. Imbalance in this intricate system may cause wound edge opening, increased risk of infection, and compromised outcome. Early biological events, e.g., tissue reperfusion, inflammation, and epithelialization maintain and sustain uneventful wound healing [6,10,14,54,55]. A failure in tissue perfusion and epithelialization and uncontrolled inflammatory responses could lead to wound instability and inferior outcome. Therefore, monitoring the clinical representations of these critical healing events and evaluating the degree of stability by not only visual examination but also functional evaluation by gentle palpation, compression, provocation, and pull of the wound could lead to more useful healing information. CBCT has been validated in the literature for its clinically acceptable accuracy in bone measurements [23,56–61]. Emerging imaging methods, e.g., ultrasound can evaluate the wound edge in cross-sectional view, quantify blood flow, and tissue elasticity, etc., and laser speckle for superficial blood flow, thus can potentially provide objective and quantifiable measurements of wound healing status [16,28,62–64].
4.3. Versatile in evaluation timing and purposes
This index could be a useful tool for clinicians to document wound healing status at different time points for various surgical procedures, e.g., periodontal tissue regeneration, soft tissue plastic surgery, ridge augmentation, etc. Previous indices mainly focus on wound healing at specific time points, e.g., 1-2 weeks [22] and for evaluation of a certain procedure. The MAPS evaluates fundamental wound healing components and therefore envisions accommodating assessment of oral wound healing from different types of procedures. Together the individual scores of A, and P with baseline measurements explain about 77% of the variability in bone changes (using the cross-validated estimate). It is also an aim of MAPS to guide the check-up frequency, selection of follow-up procedures, and assignment of treatment outcomes/prognosis. Each domain has different focuses and evaluations, potentially leading to the identification of a specific failing component within the complicated healing system.
4.4. Research indications
These preliminary data suggest a potential use of this MAPS index for systematically evaluating wound healing after GBR and predicting hard tissue healing outcome. Based on this framework, this index system can be further validated by including a larger group of representative examiners with mixed surgical experiences. A prospective study can be designed to test the predictability of this system for not only hard tissue regeneration of various defect sizes but also soft tissue reconstructive procedures for non-esthetic as well as esthetic indications.
4.5. Clinical applications
The MAPS index provides clinicians with a comprehensive tool to assess and monitor wound healing outcomes, considering the key components of biomechanical, aesthetic/anatomical, pathophysiological, and subject-related variables. This proposal could be simplified by giving a summary score for each domain. This standardized approach to assessing wound healing outcomes could enable clinicians to deliver more effective and personalized would monitoring protocol, once validated by larger-scale studies.
5. Study limitations
The results of this study are based on a specific surgical indication, i.e., minor lateral ridge augmentation, relatively small sample size, a retrospective evaluation of wound healing by reviewing clinical photos and patients’ feedback. External validation is a crucial next step to assess the prediction accuracy of the MAPS scores. We acknowledge that some parameters are currently subjective. In clinical settings, where efficiency is critical, a certain level of subjectivity may be unavoidable. However, tissue changes can be objectively quantified for research purposes using intraoral scanners, ensuring greater reproducibility and precision.
6. Conclusions
The MAPS Index was introduced, encompassing the biomechanical, aesthetic/anatomical, pathophysiologic, and subject-related domains that are separately evaluated and yet collectively considered. Preliminary data show its potential of correlating bone augmentation outcome and usefulness for further understanding of the wound healing steps and guidance of wound management to benefit patients’ welfare.
Acknowledgments
The authors would like to appreciate Drs. Hom-Lay Wang, Shan-Huey Yu, Muhammad Saleh, Hamoun Sabri, and Mrs. Alice Ou at the University of Michigan, Ann Arbor, Michigan, for their support, mentoring and coordinating with IRB.
References
- 1. Marini L, Rojas MA, Sahrmann P, Aghazada R, Pilloni A. Early Wound Healing Score: a system to evaluate the early healing of periodontal soft tissue wounds. J Periodontal Implant Sci. 2018;48(5):274–83. pmid:30405935
- 2. Pippi R. Post-Surgical Clinical Monitoring of Soft Tissue Wound Healing in Periodontal and Implant Surgery. Int J Med Sci. 2017;14(8):721–8. pmid:28824306
- 3. Makki AZ, Nassar AA, Alharbi WM, Bisharah WF, Alabdali MA, Alqurashi AM, et al. Evaluation of post-extraction healing after atraumatic axial tooth extraction using Benex system II versus conventional extraction: Randomized control trial. Saudi Dent J. 2021;33(8):923–8. pmid:34916765
- 4. Broughton G 2nd, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg. 2006;117(7 Suppl):12S-34S. pmid:16799372
- 5. Betancourt AR, Samal A, Chan H-L, Kripfgans OD. Overview of Ultrasound in Dentistry for Advancing Research Methodology and Patient Care Quality with Emphasis on Periodontal/Peri-implant Applications. Zeitschrift für Medizinische Physik. 2023.
- 6. Cho Y-D, Kim K-H, Lee Y-M, Ku Y, Seol Y-J. Periodontal Wound Healing and Tissue Regeneration: A Narrative Review. Pharmaceuticals (Basel). 2021;14(5):456. pmid:34065862
- 7. Hagenaars S, Louwerse PHG, Timmerman MF, Van der Velden U, Van der Weijden GA. Soft-tissue wound healing following periodontal surgery and Emdogain application. J Clin Periodontol. 2004;31(10):850–6. pmid:15367188
- 8. Hollander JE, Singer AJ, Valentine S, Henry MC. Wound registry: development and validation. Ann Emerg Med. 1995;25(5):675–85. pmid:7741347
- 9. Huang L-H, Neiva REF, Wang H-L. Factors affecting the outcomes of coronally advanced flap root coverage procedure. J Periodontol. 2005;76(10):1729–34. pmid:16253095
- 10. Kleinheinz J, Büchter A, Kruse-Lösler B, Weingart D, Joos U. Incision design in implant dentistry based on vascularization of the mucosa. Clin Oral Implants Res. 2005;16(5):518–23. pmid:16164456
- 11. Belkhede SG, Salaria SK, Aggarwal R. Comparative evaluation of the platelet-rich fibrin bandage versus gelatin sponge-assisted palatal wound healing of free gingival graft donor site: A case series. J Indian Soc Periodontol. 2019;23(6):589–92. pmid:31849408
- 12. Bodo M, Settle T, Royal J, Lombardini E, Sawyer E, Rothwell SW. Multimodal noninvasive monitoring of soft tissue wound healing. J Clin Monit Comput. 2013;27(6):677–88. pmid:23832619
- 13. Burkhardt R, Lang NP. Role of flap tension in primary wound closure of mucoperiosteal flaps: a prospective cohort study. Clin Oral Implants Res. 2010;21(1):50–4. pmid:20070747
- 14. Burkhardt R, Lang NP. Influence of suturing on wound healing. Periodontol 2000. 2015;68(1):270–81. pmid:25867989
- 15. Burkhardt R, Preiss A, Joss A, Lang NP. Influence of suture tension to the tearing characteristics of the soft tissues: an in vitro experiment. Clin Oral Implants Res. 2008;19(3):314–9. pmid:18177431
- 16. Fazekas R, Molnár E, Mikecs B, Lohinai Z, Vág J. A novel approach to monitoring graft neovascularization in the human gingiva. JoVE (Journal of Visualized Experiments). 2019;143:e58535.
- 17. Kaner D, Soudan M, Zhao H, Gaßmann G, Schönhauser A, Friedmann A. Early Healing Events after Periodontal Surgery: Observations on Soft Tissue Healing, Microcirculation, and Wound Fluid Cytokine Levels. Int J Mol Sci. 2017;18(2):283. pmid:28134829
- 18. RG L, RS T, T H. Effectiveness of benzydamine HC1 in the treatment of periodontal post-surgical patients. Res Clin Forums. 1988.
- 19. Pippi R, Santoro M, Cafolla A. The effectiveness of a new method using an extra-alveolar hemostatic agent after dental extractions in older patients on oral anticoagulation treatment: an intrapatient study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(1):15–21. pmid:25817129
- 20. Quinn JV, Wells GA. An assessment of clinical wound evaluation scales. Acad Emerg Med. 1998;5(6):583–6. pmid:9660284
- 21. Tonetti MS, Fourmousis I, Suvan J, Cortellini P, Brägger U, Lang NP, et al. Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects. J Clin Periodontol. 2004;31(12):1092–8. pmid:15560811
- 22. Wachtel H, Schenk G, Böhm S, Weng D, Zuhr O, Hürzeler MB. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study. J Clin Periodontol. 2003;30(6):496–504. pmid:12795787
- 23. Huang Y, Dessel JV, Depypere M, EzEldeen M, Iliescu AA, Santos ED, et al. Validating cone-beam computed tomography for peri-implant bone morphometric analysis. Bone Res. 2014;2:14010. pmid:26273522
- 24. Lim G, Lin G-H, Monje A, Chan H-L, Wang H-L. Wound Healing Complications Following Guided Bone Regeneration for Ridge Augmentation: A Systematic Review and Meta-Analysis. Int J Oral Maxillofac Implants. 2018;33(1):41–50. pmid:28938030
- 25. Masse JF, Landry RG, Rochette C, Dufour L, Morency R, D’Aoust P. Effectiveness of soft laser treatment in periodontal surgery. Int Dent J. 1993;43(2):121–7. pmid:8320005
- 26. Quinn JV, Drzewiecki A, Li MM, Stiell IG, Sutcliffe T, Elmslie TJ, et al. A randomized, controlled trial comparing a tissue adhesive with suturing in the repair of pediatric facial lacerations. Ann Emerg Med. 1993;22(7):1130–5. pmid:8517562
- 27. Quinn JV, Drzewiecki AE, Stiell IG, Elmslie TJ. Appearance scales to measure cosmetic outcomes of healed lacerations. Am J Emerg Med. 1995;13(2):229–31. pmid:7893315
- 28. Retzepi M, Tonetti M, Donos N. Comparison of gingival blood flow during healing of simplified papilla preservation and modified Widman flap surgery: a clinical trial using laser Doppler flowmetry. J Clin Periodontol. 2007;34(10):903–11. pmid:17850609
- 29. Araújo MG, Lindhe J. Dimensional ridge alterations following tooth extraction. An experimental study in the dog. J Clin Periodontol. 2005;32(2):212–8. pmid:15691354
- 30. Araújo MG, Lindhe J. Ridge alterations following tooth extraction with and without flap elevation: an experimental study in the dog. Clin Oral Implants Res. 2009;20(6):545–9. pmid:19515033
- 31. Araújo MG, Lindhe J. Ridge preservation with the use of Bio-Oss collagen: A 6-month study in the dog. Clin Oral Implants Res. 2009;20(5):433–40. pmid:19522974
- 32. Araújo MG, Silva CO, Misawa M, Sukekava F. Alveolar socket healing: what can we learn? Periodontology 2000. 2015;68(1):122-34.
- 33. Avila-Ortiz G, Chambrone L, Vignoletti F. Effect of alveolar ridge preservation interventions following tooth extraction: A systematic review and meta-analysis. J Clin Periodontol. 2019;46 Suppl 21:195–223. pmid:30623987
- 34.
Avila‐Ortiz G, Gonzalez‐Martin O, Couso‐Queiruga E, Wang Hl. The peri-implant phenotype. 2020.
- 35.
Barootchi S, Wang H-L, Ravida A, Ben Amor F, Riccitiello F, Rengo C. Ridge preservation techniques to avoid invasive bone reconstruction: A systematic review and meta-analysis: Naples Consensus Report Working Group C. 2019.
- 36. Cardaropoli G, Araújo M, Lindhe J. Dynamics of bone tissue formation in tooth extraction sites. An experimental study in dogs. J Clin Periodontol. 2003;30(9):809–18. pmid:12956657
- 37. Garcia J, Dodge A, Luepke P, Wang H-L, Kapila Y, Lin G-H. Effect of membrane exposure on guided bone regeneration: A systematic review and meta-analysis. Clin Oral Implants Res. 2018;29(3):328–38. pmid:29368353
- 38. MacBeth N, Trullenque-Eriksson A, Donos N, Mardas N. Hard and soft tissue changes following alveolar ridge preservation: a systematic review. Clin Oral Implants Res. 2017;28(8):982–1004. pmid:27458031
- 39. Annibali S, Bignozzi I, Sammartino G, La Monaca G, Cristalli MP. Horizontal and vertical ridge augmentation in localized alveolar deficient sites: a retrospective case series. Implant Dent. 2012;21(3):175–85. pmid:22614844
- 40. Urban IA, Nagursky H, Lozada JL. Horizontal ridge augmentation with a resorbable membrane and particulated autogenous bone with or without anorganic bovine bone-derived mineral: a prospective case series in 22 patients. Int J Oral Maxillofac Implants. 2011;26(2):404–14. pmid:21483894
- 41. Chan H-L, Lin G-H, Fu J-H, Wang H-L. Alterations in bone quality after socket preservation with grafting materials: a systematic review. Int J Oral Maxillofac Implants. 2013;28(3):710–20. pmid:23748301
- 42. Chao Y-C, Chang P-C, Fu J-H, Wang H-L, Chan H-L. Surgical Site Assessment for Soft Tissue Management in Ridge Augmentation Procedures. Int J Periodontics Restorative Dent. 2015;35(5):e75-83. pmid:26357705
- 43. Wang H-L, Boyapati L. “PASS” principles for predictable bone regeneration. Implant Dent. 2006;15(1):8–17. pmid:16569956
- 44. Barootchi S, Tavelli L, Majzoub J, Chan HL, Wang HL, Kripfgans OD. Ultrasonographic Tissue Perfusion in Peri-implant Health and Disease. J Dent Res. 2022;101(3):278–85. pmid:34515570
- 45. Cortellini P, Tonetti MS. Clinical concepts for regenerative therapy in intrabony defects. Periodontol 2000. 2015;68(1):282–307. pmid:25867990
- 46. Couso-Queiruga E, Stuhr S, Tattan M, Chambrone L, Avila-Ortiz G. Post-extraction dimensional changes: A systematic review and meta-analysis. J Clin Periodontol. 2021;48(1):126–44. pmid:33067890
- 47. De Risi V, Clementini M, Vittorini G, Mannocci A, De Sanctis M. Alveolar ridge preservation techniques: a systematic review and meta-analysis of histological and histomorphometrical data. Clin Oral Implants Res. 2015;26(1):50–68. pmid:27007188
- 48. Machtei EE. The effect of membrane exposure on the outcome of regenerative procedures in humans: a meta-analysis. J Periodontol. 2001;72(4):512–6. pmid:11338304
- 49. Fontana F, Maschera E, Rocchietta I, Simion M. Clinical classification of complications in guided bone regeneration procedures by means of a nonresorbable membrane. Int J Periodontics Restorative Dent. 2011;31(3):265–73. pmid:21556383
- 50. Rodriguez AB, Alhachache S, Velasquez D, Chan H-L. A systematic review of oral wound healing indices. PLoS One. 2024;19(2):e0290050. pmid:38330054
- 51.
Landry RG. Effectiveness of benzydamine HC1 in the treatment of periodontal post-surgical patients: Faculty of Dentistry, University of Toronto; 1985.
- 52. Sanz M, Simion M, Abbas F, Aroca S, Artzi Z, Burkhardt R, et al. Surgical techniques on periodontal plastic surgery and soft tissue regeneration: consensus report of Group 3 of the 10th European Workshop on Periodontology. Journal of clinical periodontology. 2014;41(S1):S92–7.
- 53. Velvart P, Peters CI, Peters OA. Soft tissue management: suturing and wound closure. Endodontic Topics. 2005;11(1):179–95.
- 54. Rodriguez A, Velasquez D, Chan H. Review of intraoral vasculature and implications on incision designs of periodontal and implant surgeries. International Journal of Periodontics and Restorative Dentistry. International Journal of Periodontics and Restorative Dentistry In press.
- 55. Sculean A, Gruber R, Bosshardt DD. Soft tissue wound healing around teeth and dental implants. J Clin Periodontol. 2014;41 Suppl 15:S6-22. pmid:24641001
- 56. Fernandes TMF, Adamczyk J, Poleti ML, Henriques JFC, Friedland B, Garib DG. Comparison between 3D volumetric rendering and multiplanar slices on the reliability of linear measurements on CBCT images: an in vitro study. J Appl Oral Sci. 2015;23(1):56–63. pmid:25004053
- 57. Hassan NA, Al-Radha ASD. CBCT Evaluation of Quality and Quantity of Bones for Immediate Implant Treatment Planning in Central Incisor Area in relation to Arch Form. ScientificWorldJournal. 2023;2023:8863318. pmid:37101786
- 58. Kasaven CP, Ivekovic S, McIntyre GT, Gillgrass T, Thomson DA, Menhinick A, et al. Validation of the volumetric measurement of a simulated maxillary alveolar bone defect using cone-beam computed tomography. Cleft Palate Craniofac J. 2013;50(6):e115-20. pmid:23157577
- 59. Loubele M, Maes F, Schutyser F, Marchal G, Jacobs R, Suetens P. Assessment of bone segmentation quality of cone-beam CT versus multislice spiral CT: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(2):225–34. pmid:16876067
- 60. Parsa A, Ibrahim N, Hassan B, van der Stelt P, Wismeijer D. Bone quality evaluation at dental implant site using multislice CT, micro-CT, and cone beam CT. Clin Oral Implants Res. 2015;26(1):e1-7. pmid:24325572
- 61. Pauwels R, Jacobs R, Singer SR, Mupparapu M. CBCT-based bone quality assessment: are Hounsfield units applicable?. Dentomaxillofac Radiol. 2015;44(1):20140238. pmid:25315442
- 62. Chan H-L, Kripfgans OD. Ultrasonography for diagnosis of peri-implant diseases and conditions: a detailed scanning protocol and case demonstration. Dentomaxillofac Radiol. 2020;49(7):20190445. pmid:32017634
- 63. Chan H-L, Sinjab K, Li J, Chen Z, Wang H-L, Kripfgans OD. Ultrasonography for noninvasive and real-time evaluation of peri-implant tissue dimensions. J Clin Periodontol. 2018;45(8):986–95. pmid:29757464
- 64. Rodriguez A, Velasquez D, Chan HL. Review of Intraoral Vasculature and Implications on Incision Designs of Periodontal and Implant Surgeries. International Journal of Periodontics and Restorative Dentistry 2022.